EUVIMEDEUVIMED entdecken
Video/Audio

Ferroptosis Induction in Glioma by Calceolarioside A via Modulation of the PI3K/Akt/Nrf2 Pathway

Yongdong Liu, Yufang Liu, Aiwu Li

Journal of Visualized Experiments · 2026

DOI: 10.3791/6683 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Yongdong Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Qilu Hospital of Shandong University; Department of Pediatric Surgery, Weifang Peoples Hospital. Hauptthemen laut MEDLINE: Glioma, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Ferroptosis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktFerroptosisNF-E2-Related Factor 2HumansSignal TransductionCell Line, TumorAnimals

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Qilu Hospital of Shandong University; Department of Pediatric Surgery, Weifang Peoples Hospital.
  • Department of Burn, Weifang Peoples Hospital.
  • Department of Pediatric Surgery, Qilu Hospital of Shandong University; liaiwu@qiluhospital.com.

Zitieren

APA

Liu, Y., Liu, Y., & Li, A. (2026). Ferroptosis Induction in Glioma by Calceolarioside A via Modulation of the PI3K/Akt/Nrf2 Pathway. Journal of Visualized Experiments. https://doi.org/10.3791/6683

Vancouver

Liu Y, Liu Y, Li A. Ferroptosis Induction in Glioma by Calceolarioside A via Modulation of the PI3K/Akt/Nrf2 Pathway. Journal of Visualized Experiments. 2026. doi:10.3791/6683

BibTeX
@article{Liu2026,
  author = {Liu, Yongdong and Liu, Yufang and Li, Aiwu},
  title = {Ferroptosis Induction in Glioma by Calceolarioside A via Modulation of the PI3K/Akt/Nrf2 Pathway},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/6683}
}
Kostenlos starten →